ℹ️
🇬🇧
Search
Search for people relevant for "reducts"
reducts
Person
Class
Person
Publication
Programmes
Export current view
prof. Ing. Vladimír Wsól Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
2 study programmes
14 classes
198 publications
Study programme
programme
Xenobiochemistry and Pathobiochemistry
+1
🇨🇿 PhD. |
Faculty of Pharmacy in Hradec Králové
Classes
class
General Biochemistry
+1
GAF141 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry
+1
GAF237 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry - Practical Training
+3
GAF267 |
Faculty of Pharmacy in Hradec Králové
class
Selected Chapters from General Biochemistry
+1
GDEXP04 |
Faculty of Pharmacy in Hradec Králové
class
The Defense of Doctoral Thesis
+1
GDEXPODP1 |
Faculty of Pharmacy in Hradec Králové
class
Xenobiochemistry and Patobiochemistry
+1
GDEXPSDZ1 |
Faculty of Pharmacy in Hradec Králové
Load more classes (4)
Publications
publication
Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily
2012 |
Faculty of Pharmacy in Hradec Králové
publication
A simple identification of novel carbonyl reducing enzymes in the metabolism of the tobacco specific carcinogen NNK
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Enzyme stereospecificity as a powerful tool in searching for new enzymes
2010 |
Central Library of Charles University
publication
Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin
2009 |
Central Library of Charles University
publication
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3
2008 |
Central Library of Charles University
publication
Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man
2007 |
Publication without faculty affiliation
publication
Reductive biotransformation of the potential cytostatic drug oracin at chiral level in rats in vitro and in vivo
1997 |
Faculty of Pharmacy in Hradec Králové
Load more publications (188)
Loading network view...